Epigenetics: The role of methylation in the mechanism of action of tumor suppressor genes

被引:34
作者
Jain, PK [1 ]
机构
[1] US FDA, DETTD, OBRR, CBER, Rockville, MD 20852 USA
来源
EPIGENETICS IN CANCER PREVENTION: EARLY DETECTION AND RISK ASSESSMENT | 2003年 / 983卷
关键词
epigenetics; hypermethylation; tumor suppressor genes; histone deacetylase (HDAC); histone methylase (HMT);
D O I
10.1111/j.1749-6632.2003.tb05963.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Epigenetics is the study of mitotically heritable changes in gene expression without any changes in the primary DNA sequence. The major step in epigenetic gene regulation is gene inactivation by hypermethylation of CpG islands located in the promoter region. Specific enzymes and methylated DNA binding proteins play a major role in causing reduced expression of tumor suppressor genes, resulting in tumor formation and its progression. Prevention approaches are needed to avoid tumor formation. One approach to inhibiting inactivation of tumor suppressor genes is to use chemical agents such as 5-azacytidine to prevent hypermethylation of DNA. Increased understanding of the mechanism of epigenetic silencing and the identification of additional molecular mechanisms (e.g., histone methylases) that may be targeted by pharmaceutical interventions may lead to more preventive strategies. The current status of the epigenetic regulation of tumor suppressor genes is discussed in this review article.
引用
收藏
页码:71 / 83
页数:13
相关论文
共 81 条
[1]   DNA methylation and ovarian cancer [J].
Ahluwalia, A ;
Yan, P ;
Hurteau, JA ;
Bigsby, RM ;
Jung, SH ;
Huang, THM ;
Nephew, KP .
GYNECOLOGIC ONCOLOGY, 2001, 82 (02) :261-268
[2]  
Akhtar M, 2001, CANCER RES, V61, P2399
[3]   RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours [J].
Astuti, D ;
Agathanggelou, A ;
Honorio, S ;
Dallol, A ;
Martinsson, T ;
Kogner, P ;
Cummins, C ;
Neumann, HPH ;
Voutilainen, R ;
Dahia, P ;
Eng, C ;
Maher, ER ;
Latif, F .
ONCOGENE, 2001, 20 (51) :7573-7577
[4]   Selective recognition of methylated lysine 9 on histone H3 by the HP1 chromo domain [J].
Bannister, AJ ;
Zegerman, P ;
Partridge, JF ;
Miska, EA ;
Thomas, JO ;
Allshire, RC ;
Kouzarides, T .
NATURE, 2001, 410 (6824) :120-124
[5]   Genomic imprinting in mammals [J].
Bartolomei, MS ;
Tilghman, SM .
ANNUAL REVIEW OF GENETICS, 1997, 31 :493-525
[6]   DNA hypermethylation in tumorigenesis - epigenetics joins genetics [J].
Baylin, SB ;
Herman, JG .
TRENDS IN GENETICS, 2000, 16 (04) :168-174
[7]  
Baylin SB, 1998, ADV CANCER RES, V72, P141
[8]   ACTIVATION OF MAMMALIAN DNA METHYLTRANSFERASE BY CLEAVAGE OF A ZN BINDING REGULATORY DOMAIN [J].
BESTOR, TH .
EMBO JOURNAL, 1992, 11 (07) :2611-2617
[9]   A mammalian protein with specific demethylase activity for mCpG DNA [J].
Bhattacharya, SK ;
Ramchandani, S ;
Cervoni, N ;
Szyf, M .
NATURE, 1999, 397 (6720) :579-583
[10]   p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus [J].
Bian, YS ;
Osterheld, MC ;
Fontolliet, C ;
Bosman, FT ;
Benhattar, J .
GASTROENTEROLOGY, 2002, 122 (04) :1113-1121